Literature DB >> 6380179

Single versus multiple dose doxycycline prophylaxis in elective colorectal surgery.

G Göransson, I Nilsson-Ehle, S A Olsson, B G Petersson, S Bengmark.   

Abstract

One hundred and two patients undergoing elective colorectal surgery were randomized in a prospective but "non-blind" way into two groups. The first group received 0.4 g of doxycycline preoperatively and the second group 0.2 g of doxycycline preoperatively and 0.1 g of doxycycline on the first, second and third postoperative day. All doxycycline was administered by intravenous infusion. The infection rate was 10% in the "one-dose" treatment group and 10% in the "four-dose" treatment group. It is thus concluded that 0.4 g of doxycycline preoperatively results in an acceptable rate of postoperative infections, which may be explained by the satisfactory concentration of doxycycline up till three days after administration. The advantage of "one-dose" treatment compared to "four-dose" treatment from practical and economical standpoints are obvious.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380179

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Identification and antibiotic prophylaxis of high-risk patients in elective colorectal surgery.

Authors:  A Törnqvist; A Forsgren; L Leandoer; J Ursing
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

3.  Single-dose chemoprophylaxis in elective colorectal surgery. A comparison between doxycycline plus metronidazole and doxycycline.

Authors:  L Bergman; J H Solhaug
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

4.  Short-term intravenous antimicrobial prophylaxis for elective rectal cancer surgery: results of a prospective randomized non-inferiority trial.

Authors:  Keiichiro Ishibashi; Hideyuki Ishida; Kouki Kuwabara; Tomonori Ohsawa; Norimichi Okada; Masaru Yokoyama; Kensuke Kumamoto
Journal:  Surg Today       Date:  2013-08-29       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.